Michał Piątek

assistant professor

Opole University

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Michał Piątek is an assistant professor at Opole University in Poland. His research primarily focuses on oncology, with recent articles exploring topics such as gastric carcinoma, pancreatic adenocarcinoma, and breast cancer. He has contributed to the understanding of immune response in tumors and prognostic factors in various carcinomas.

Articles (6)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Collaborators (5)

Rafał Pęksa

Medical University of Gdansk

POLAND

View details

Sławomir Mrowiec

Medical University of Silesia

POLAND

View details

Wojciech Biernat

Professor

Gdański Uniwersytet Medyczny

POLAND

View details

BARBARA RADECKA

Head of Dept

Opole University

POLAND

View details

Adrian Perdyan

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michał Piątek

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study

Sarcina ventriculi: an unexpected herald of gastric carcinoma

Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes

Galectin-9 expression on tumor-associated immune cells is associated with favorable clinicopathological features and better outcomes in oral squamous cell carcinoma

Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes

Collaborators (5)

Rafał Pęksa

Sławomir Mrowiec

Wojciech Biernat

BARBARA RADECKA

Adrian Perdyan

Make your next move.